Sodium-dependent glucose transporter 2 inhibitors effects on myocardial function in patients with type 2 diabetes and asymptomatic heart failure

Sodium-dependent glucose transporter 2 inhibitors (SGLT2i) have shown efficacy in reducing heart failure (HF) burden in a very heterogeneous groups of patients, raising doubts about some contemporary assumptions of their mechanism of action. We previously published a prospective observational study...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	World journal of cardiology 2024-08, Vol.16 (8), p.448
Hauptverfasser:	Grubić Rotkvić, Petra, Rotkvić, Luka, Đuzel Čokljat, Ana, Cigrovski Berković, Maja
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!